01 1Zhejiang Haizhou Pharmaceutical
01 1METHOCARBAMOL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-07-19
Pay. Date : 2019-05-22
DMF Number : 33659
Submission : 2019-03-26
Status : Active
Type : II
20
Zhejiang Haizhou Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHOCARBAMOL, with a corresponding US DMF Number 33659.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 19, 2019, and payment made on May 22, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
